MMSI

MERIT MEDICAL SYSTEMS INC

Nasdaq · CIK 856982

Last close85.37
Daily change-0.78 (-0.91%)
10 Years gain+250.45%
Dividends TTM0
Dividend yield0.00%

Fundamental Analysis

MMSI · STANDARD

SIC 3841 · Surgical & Medical Instruments & Apparatus · Fiscal year end 1231

Screener
Fundamental
62.6
Momentum
52.9
Acceleration
51.8
Confidence
91.0
Annual Revenue17
Quarterly Revenue71
Annual CFO17
Balance SheetAvailable
RankingEligible

Score Breakdown

Growth15.5 / 25
Quality20.7 / 25
Capital Efficiency8.0 / 20
Balance Sheet9.1 / 15
Shareholder Economics6.2 / 10
Forward Indicators0.0 / 5

Signals

Gross margin expansionGross margin improved by 1.8351 percentage points.
Operating leverageOperating margin improved by 0.5758 percentage points.
ROIC expansionROIC improved by 0.0442 percentage points.
Net debt reductionNet debt declined versus the comparison period.
Share count reductionDiluted share count declined 2.0758%.
Strong operating leverageOperating income is growing faster than revenue while operating margin expands.

Key Metrics

Revenue Growth TTM15.53%OK
Revenue CAGR 3Y9.61%OK
Gross Margin49.18%OK
Operating Margin12.38%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC7.06%OK
Incremental Operating Margin 3Y29.08%OK
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y-2.08%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL

Financial History

PeriodRevenueGross ProfitOperating IncomeCFOFCFGross MarginOp MarginFCF MarginROICShares
2025 FY Dec 31, 2025$1.52B$738.27M$184.72M$297.37M$215.66M48.7%12.19%14.23%7.71%60.46M
2025 FY Dec 31, 2024$1.36B$643.33M$155.69M$220.80M$185.66M47.43%11.48%13.69%7.88%59.37M
2025 FY Dec 31, 2023$1.26B$583.87M$123.94M$145.15M$110.86M46.44%9.86%8.82%7.67%58.36M
2024 FY Dec 31, 2022$1.15B$519.10M$87.56M$114.29M$69.26M45.1%7.61%6.02%6.32%57.67M
2023 FY Dec 31, 2021$1.07B$485.33M$60.92M$147.23M$119.29M45.16%5.67%11.1%4.44%57.36M

Formula Trace

MetricValueFormulaStatusSource
Revenue TTM$1.57Bsum latest 4 fiscal quarters RevenueOK0000856982-26-000044, 0000856982-25-000056
Revenue Growth TTM15.53%Revenue_TTM / Revenue_TTM_1Y_ago - 1OK0000856982-26-000044, 0000856982-25-000056
Revenue CAGR 3Y9.61%(Revenue_current / Revenue_3Y_ago)^(1/3) - 1OK0000856982-26-000008
Revenue CAGR 5Y9.48%(Revenue_current / Revenue_5Y_ago)^(1/5) - 1OK0000856982-26-000008
Gross Profit CAGR 3Y12.46%(GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1OK0000856982-26-000008
Operating Income Growth21.16%OperatingIncome_current / OperatingIncome_prior_year - 1OK0000856982-26-000044, 0000856982-25-000056
FCF Growthn/aFCF_current / FCF_prior_year - 1INSUFFICIENT_HISTORYderived
Revenue Growth Accelerationn/a0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3)INSUFFICIENT_HISTORYderived
Gross Profit Accelerationn/a0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3)INSUFFICIENT_HISTORYderived
Operating Income Accelerationn/a0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3)INSUFFICIENT_HISTORYderived
FCF Accelerationn/a0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3)INSUFFICIENT_HISTORYderived
Gross Margin49.18%Gross Profit / RevenueOK0000856982-26-000044, 0000856982-25-000056
Operating Margin12.38%Operating Income / RevenueOK0000856982-26-000044, 0000856982-25-000056
ROIC7.06%NOPAT / Average Invested CapitalOK0000856982-26-000044, 0000856982-25-000056
Net Debt / CFOn/aNet Debt / CFONOT_MEANINGFUL0000856982-26-000044
Current Ratio4.2xCurrent Assets / Current LiabilitiesOKderived
Cash / Debt0.61x(Cash + Short-term Investments) / Total DebtOK0000856982-26-000044
Revenue per Diluted Share$26.12Revenue / Diluted SharesOK0000856982-26-000044, 0000856982-25-000056